David Zhen, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Cornerstone Pharmaceuticals
    Topic:
    Research Funding
    Date added:
    10/04/2024
    Date updated:
    08/05/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Daiichi Sankyo, Inc
    Topic:
    Research Funding
    Date added:
    10/04/2024
    Date updated:
    08/05/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Eli Lilly
    Topic:
    Research Funding
    Date added:
    10/04/2024
    Date updated:
    08/05/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Legend Biotech
    Topic:
    Research Funding
    Date added:
    10/04/2024
    Date updated:
    08/05/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Roche/Genentech
    Topic:
    Research Funding
    Date added:
    10/04/2024
    Date updated:
    08/05/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pfizer/Seagen
    Topic:
    Research Funding
    Date added:
    10/04/2024
    Date updated:
    08/05/2025

Pages

Return to Coeur d’Alene Hematology Oncology Conference: Focus on Precision Guided Management